Clinical trial
GW873140 In Combination With Kaletra In HIV Infected Subjects
NCT00102778 · ViiV Healthcare, Industry · Terminated
Key facts
| NCT number | NCT00102778 |
|---|---|
| Title | GW873140 In Combination With Kaletra In HIV Infected Subjects |
| Official title | A Phase IIb, 96 Week, Randomized, Open-label Multicenter, Parallel Group, Repeat Dose Study to Evaluate the Safety, Tolerability, PK and Antiviral Effect of Different Doses and Regimens of GW873140 in Combination With Kaletra (Lopinavir and Ritonavir) in HIV-1 Infected Antiretroviral Therapy naïve… |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection |
| Intervention type | Drug |
| Interventions | GW873140, Kaletra (lopinavir/ritonavir) |
| Enrollment | 175 |
| Start date | Dec 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Feb 2, 2005 |
| Last update posted | May 30, 2017 |
| Countries | Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: